The latest in research questioning statins
The bulletin of February 20, 2015 – this is the latest in research questioning statins
Tampa, Florida (Feb. 20, 2015) – Hailed as miracle drugs when they hit the market two decades ago, statins, the cholesterol-lowering drugs prescribed to prevent heart attacks, are not as effective nor as safe as we have been led to believe, say Dr. David M. Diamond, a professor of psychology, molecular pharmacology and physiology at the University of South Florida, and Dr. Uffe Ravnskov, an independent health researcher and an expert in cholesterol and cardiovascular disease.
According to Diamond and Ravnskov, statins produce a dramatic reduction in cholesterol levels, but they have “failed to substantially improve cardiovascular outcomes.” They further state that the many studies touting the efficacy of statins have not only neglected to account for the numerous serious adverse side effects of the drugs, but supporters of statins have used what the authors refer to as “statistical deception” to make inflated claims about their effectiveness.
Their critique of the exaggerated claims regarding statins’ ability to prevent strokes, heart attacks and heart disease-related deaths on a large scale has been published in the medical journal “Expert Review of Clinical Pharmacology” at http://informahealthcare.com/
Their paper is an analysis of the data in the statin trials which led them to conclude that “statin advocates have used statistical deception to create the illusion that statins are ‘wonder drugs,’ when the reality is that their modest benefits are more than offset by their adverse effects.”
Majid Ali, MD
How did people get so duped?
Under a microscope, new plaques in arteries rarely, if ever, show cholesterol crystals when examined under microscopes. In old and large plaques, cholesterol deposits are nearly always found in the deep regions, away from the plaque surface facing the flowing blood. These basic facts of pathology reveal that cholesterol is deposited after plaques have enlarged and caused deep tissue injury in the arterial wall. And yet, the public firmly believes that plaques are caused by cholesterol, and statin drugs are necessary to lower blood cholesterol levels (for decades, of course).
The above article and research supports that which some of us have been saying for decades – Statins dont do what they say they do.
Cholesterol mediates cellular cross talk. Low blood cholesterol levels increase the risk of all brain disorders in which this association has been investigated. Natural, unrancid cholesterol is an antioxidant and anti-inflammatory substance of great importance in all considerations of health preservation and disease prevention. Oxygen keeps cholesterol in its natural and healthful form. Cholesterol turns rancid (oxidized) in states of dysfunctional oxygen metabolism (dysox). The media have shown no interest in these basic facts of cholesterol science. Why offend the all powerful statin makers?
The True Science Story of Plaques
The real culprits in the cause of heart attacks, strokes, and kidney failures are toxic acids, increased free radical activity, and synthetic chemicals. These elements damage blood components, making them sticky, initiating the formation of microclots and microplaques. Such clots and plaques, in turn, damage cells lining blood vessels called endo cells (endo is short for endothelial cells). This is the beginning of plaque formation. So, plaques in early stages are composed of dead and dying blood cells, dead and dying endo cells, and inflammatory cells. As they enlarge, they damage the connective tissue and the muscle cells in vessel walls. This is the true story of plaques in blood vessels which is well known to pathologists.
Healthy, unrancid cholesterol protects the endo cells and prevents heart attacks, strokes, and kidney failures. The media are not interested in this story either—and for the same reason. Cholesterol has but one molecular formula and one three-dimensional structure. If there is only one cholesterol, how does it become “good cholesterol” and “bad cholesterol”? The media are not curious about this. Cholesterol molecules wear garbs of different colors and shapes—carrying protein and cell membrane receptors in biology lingo—and so look different. The the real issue in the sordid cholesterol story is “the protein problem.” However, there are no drugs—read, profits—in correcting the protein problem, which can be addressed only by restoring oxygen’s detergent and signaling functions.
“But don’t the foamy cells in vascular plaques contain cholesterol?” some drug doctors might challenge. Yes, they do, but essentially in the same proportion as in the blood. This brings us to another important story to which the media have been blind. No money here either. Consider this: The so-called “bad” LDL cholesterol, in reality, is a large complex of proteins and fats that also contains a small amount of cholesterol, which is neither good nor bad. It is just cholesterol. The LDL complex also contains proteins, polyunsaturated fatty acids, phospholipids, and antioxidants (beta carotene and vitamin E). Cholesterol represents a small portion of the complex. The makers of cholesterol drugs—Lipitor, Crestor, Zocor, Vytorin, and others—fiercely hide this information from the statin-eating public. The media are only too happy to comply.